Your browser doesn't support javascript.
loading
Impact of Buffers on Colloidal Property and Aggregation Propensities of a Bispecific Antibody.
Majumder, Subhabrata; Wang, Wei; Alphonse Ignatius, Arun.
Afiliação
  • Majumder S; Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., Chesterfield, Missouri 63017.
  • Wang W; Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., Chesterfield, Missouri 63017.
  • Alphonse Ignatius A; Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., Chesterfield, Missouri 63017. Electronic address: arun.alphonseignatius@pfizer.com.
J Pharm Sci ; 108(3): 1139-1147, 2019 03.
Article em En | MEDLINE | ID: mdl-30391414
ABSTRACT
Bispecific antibodies represent a promising avenue whereby 2 different binding specificities of a single-chain antibody can be grafted into a common Fc fragment to generate one antibody-like molecule. Despite the promising efficacy of such modalities, they may lack manufacturability because of stability and aggregation issues. Herein, we performed a systematic buffer screening for an aggregation-prone therapeutic bispecific antibody (BsAb) during early stage development. To this end, various buffers (histidine, glutamate, acetate, and arginine) and buffer combinations, including arginine and glutamate (Arg + Glu), were evaluated for their stabilizing effects on BsAb. Specifically, we identified an equimolar combination of histidine and glutamate (His + Glu at pH 5.0) buffer that showed enhanced colloidal stability as measured by dynamic light scattering interaction parameter (kD). This implies a role of net protein-protein interaction in mediating aggregation propensity of the protein. Two-dimensional nuclear magnetic resonance and multiangle light scattering experiments suggest the formation of a reversible dimer as a potential precursor to overall aggregation process. Furthermore, 1D nuclear magnetic resonance studies suggest a unique mode of interaction of histidine with BsAb that can be modulated by other buffer components or ionic strength.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Ácido Glutâmico / Histidina Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Ácido Glutâmico / Histidina Idioma: En Ano de publicação: 2019 Tipo de documento: Article